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A novel, centrifugal disk-based micro-total analysis system (μTAS) for low cost and high throughput
semi-automated immunoassay processing was developed. A key innovation in the disposable im-
munoassay disk design is in a fluidic structure that enables very efficient micro-mixing based on a
reciprocating mechanism in which centrifugal acceleration acting upon a liquid element first gener-
ates and stores pneumatic energy that is then released by a reduction of the centrifugal acceleration,
resulting in a reversal of direction of flow of the liquid. Through an alternating sequence of high
and low centrifugal acceleration, the system reciprocates the flow of liquid within the disk to maxi-
mize incubation/hybridization efficiency between antibodies and antigen macromolecules during the
incubation/hybridization stage of the assay. The described reciprocating mechanism results in a re-
duction in processing time and reagent consumption by one order of magnitude. © 2011 American
Institute of Physics. [doi:10.1063/1.3597578]
INTRODUCTION
Immunoassays are a common standard for diagnostics of
many conditions and diseases and are one of the main research
tools used across the life sciences. Since their implementa-
tion in 1950s by Yalow and Berson1 in the form of radio-
labelled insulin assays, immunoassays have emerged as one
of the largest and fastest growing segments of in vitro diag-
nostics and clinical chemistry. Today immunoassays are most
commonly used for the detection of the presence of antibodies
and antigens for a variety of infectious diseases, as well as for
measuring the levels of macromolecules such as hormones,
growth factors, and tumor markers in bodily fluids for toxico-
logical screening and many other applications. Clinical diag-
nostic immunoassay kits are a rapidly growing business with
annual sales in the tens of billions of dollars. They are simple
and inexpensive to implement, and have high specificity and
selectivity. The working principle of immunoassays is based
on the highly specific affinity of antibodies for antigens, mak-
ing for thermodynamically stable complexes. Detection of
such complexes can be carried out in a variety of ways, such
as with radioisotopes in radio immunoassays (RIA), colori-
metric as in enzyme-linked immunosorbent assays (ELISAs),
and fluorometric like in fluoroimmunoassays.2 Furthermore,
immunoassays can be performed in a bulk solution, in which
case they are referred to as homogenous immunoassays and
on a solid surface where they are called heterogeneous im-
munoassays. The colorimetric detection of the formation of
antigen-antibody complexes is the most common and least ex-
pensive form of an immunoassay and is the foundation for the
ELISA presented in this article. The ELISA technique is com-
monly used to elucidate the concentrations of specific proteins
in a sample and has been successfully adapted to a microar-
ray format.3–5 Besides their utility in diagnostics, immunoas-
says are an important tool in drug discovery. Often, thousands
of antigens must be screened in search for the most effective
vaccine or drug, or for discovering new biomarkers. This re-
quirement makes the protein microarray a suitable tool for
such applications because it enables the simultaneous analy-
sis of a large number of proteins in a single experiment using
a relatively small sample volume.6
Immunoassays can be performed in a high throughput
and parallelized fashion by using either the ELISA plate
technique, where typically a 96-well plate runs a single
analyte simultaneously, or by the enzyme-linked immunospot
method, commonly referred to as ELISPOT technique7
where multiple analytes can be detected from a single array
on a glass slide. In an indirect colorimetric heterogeneous
ELISPOT performed for evaluating the stimulated host re-
sponse to a new vaccine, a set of antigens from an infectious
organism are spotted onto a solid support (solid phase),
such as glass, polystyrene, polymethylmethacrylate, or a
nitrocellulose membrane to make a protein microarray.8 This
microarray is then exposed to the diluted serum of a patient
that has developed immunity to the specific infectious agent,
resulting in the specific attachment of patient antibodies
(found in the serum) to the immobilized antigens. The anti-
bodies are then detected by secondary antibodies, conjugated
to an enzyme such as alkaline phosphatase, and developed
using an appropriate substrate2 to detect the presence of
0034-6748/2011/82(6)/064303/9/$30.00 © 2011 American Institute of Physics82, 064303-1
Downloaded 01 Aug 2013 to 114.70.7.203. This article is copyrighted as indicated in the abstract. Reuse of AIP content is subject to the terms at: http://rsi.aip.org/about/rights_and_permissions
064303-2 Noroozi et al. Rev. Sci. Instrum. 82, 064303 (2011)
antibody/antigen complexes.9–11 The signal intensities
quantified from precipitated chromogenic products on the
membrane reveal the antigens that elicit the best immune
responses.
The process of manually exposing the antigen microar-
rays to sera, washing, incubation with the secondary anti-
body, incubation with substrate, and analysis of the results
is labor intensive and requires a well-equipped laboratory set-
ting. Furthermore, the extended exposure to infected samples
increases the operators’ risk of infection. Today, as a stan-
dard practice, large scale automated immunoassay and ELISA
plate washer/reader liquid handling robots are used in order
to reduce the exposure risk and accelerate the process flow.
These large-scale operations are, nevertheless, inadequate for
the point of need use, and costs are prohibitive for small lab-
oratories.
For the reasons presented above, numerous efforts have
been undertaken to automate fully functional ELISAs that
are integrated on micro-structured platforms known as micro-
total analysis systems (μTAS).12–14 The aim of such studies
is not only to automate the assays but also to decrease the
consumption of sample, to minimize the footprint of the in-
strumentation involved and to reduce costs. This could make
ELISAs on μTAS platforms suitable for on-site analysis and
make them affordable for a much wider community.15–17
There is also a considerable emphasis put on speeding up the
immunoassay process, which tends to be quite slow. The lat-
ter is due to the fact that bimolecular antigen/antibody inter-
actions rely solely on molecular diffusion. The diffusion co-
efficient for large protein molecules such as antibodies is in
the order of 10−10m2/s.18 This means that each antibody can
only travel about 2.5 mm during an overnight incubation with-
out agitation. As such, only a small number of antibodies in
solution reach the solid-liquid interface to interact with their
complimentary antigens on the surface. Generally, the rate of
formation of antigen-antibody complexes, which is propor-
tional to the concentration of the antibodies and antigens, dic-
tates the required incubation time for generating a detectable
result. This is why it is desirable to introduce other transport
mechanisms such as migration and convection into the system
to cause turbulence in the antibody solution and/or to gener-
ate flow and increase the rate of formation of antigen-antibody
complexes19, 20 by employing different innovative methods.
A promising methodology that has been examined in re-
cent decades as a candidate for μTAS is the fabrication of
microfluidic systems on rotating platforms, or compact discs
(CD).21, 22 Such platforms exploit the forces induced by rotat-
ing the platform around a fixed center to drive a fluid within
the system and control its flow. Precise fluidic propulsion, reg-
ulation, and redirection is realized by carefully designing the
size of features and their proximity to each other on the plat-
form, and also by controlling the rotational speed and accel-
eration rates, hence, balancing centrifugal, Coriolis, and sur-
face forces. Beads of different sizes are often used to serve
both as solid phases functionalized with capture antigens and
to increase the interaction rate by intermittently mixing the
reagents on the disk.16–23 The rate of interaction will also
increase by flowing the antibody solution over the array of
immobilized antigens and hence increasing the rate of mass
FIG. 1. (Color online) (a) Schematic illustration of the fluidic system.
(b) Schematic illustration of antibody capture at each array element.
transport.24–26 Rotating platforms are especially suitable for
flow-through capture systems because the flow can be readily
generated by the centrifugal acceleration.
Although these CD-based microfluidic systems exhibit
superior performance characteristics for analyzing small
numbers of target molecules, they are not well suited for pro-
cessing large arrays of antigens. The shortcoming comes from
the fact that as the footprint of the array increases so does the
volume of the reagents and buffers required for running the
assay, resulting in a high rate of sample (antibody) consump-
tion. In addition, in a single-pass flow-through scheme, only
a small number of antibodies are sequestered by the antigens
immobilized on the solid phase. As a consequence of this, the
expensive and sometimes scarce sample will leave the sys-
tem unconsumed properly. This is why it desirable to flow the
sample over the array in a cyclical, or reciprocating, manner to
take advantage of favorable kinetics offered by flow-through
capture systems on an automated CD-based platform.
In this report we present a semi-automated centrifugal
microfluidic platform for faster protein microarray processing
(Fig. 1). The system is based on a novel technique introduced
recently by us for reciprocating fluid samples on a CD to en-
hance mixing in a miniaturized bioassay chamber.27 It works
by using the centrifugal acceleration field acting upon a liquid
within a rotating disk to generate and store pneumatic energy
for later use in reversing the direction of flow of the liquid as
centrifugal acceleration is reduced (by reducing angular fre-
quency). Through a sequence of steps increasing and decreas-
ing centrifugal acceleration (Fig. 2), the system allows one
to reciprocate the flow of liquid within a fluidic system. The
reciprocating fluid causes mixing and maximizes encounters
and specific interactions between molecules in the liquid and
solid phase. This results in a reduction in the time necessary to
perform a bioassay. In addition, because of the miniaturized
nature of the system, reagent consumption is minimized.
To evaluate the performance of the reciprocating fluidic
system, we developed a set of numerical simulations and com-
pared the antigen-antibody interaction results between three
different modes: flow-reciprocation, single flow-through, and
passive diffusion. Results of the simulations demonstrated
that the reciprocating flow mode yields superior capture rates
over those of the passive diffusion mode and are more com-
parable to the capture rates in single flow-through mode. To
experimentally validate the simulation results, we incubated
arrays of human sera (containing antibodies) with a solution
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FIG. 2. (Color online) (a) Time-lapse images of the system in operation. (i)
Liquid is added to the loading reservoir, (ii) compression of air in pressure
chamber as a result of high rpm, (iii) relaxation of air and pumping of liq-
uid towards the center, (iv) increase of rpm to maximum, (v) priming of the
siphon as the liquid level rises above the crest of the siphon, and (vi) the
empty system. (b) Flow reciprocation work cycle profile: angular frequency
vs. time.
containing goat anti-human Immunoglobulin G (IgG) pro-
teins conjugated to alkaline phosphatase and compared the
signal intensities for the same assay performed both manually
(passive diffusion) and using the reciprocating fluidic system.
We then calibrated the reciprocating system by optimizing pa-
rameters such as concentration of proteins on the solid phase
and in the liquid phase, incubation time, and number of recip-
rocation cycles for each step, as well as the number of washes
required to reduce non-specific adsorption in between each of
the steps.
For proof of concept, we set up an immunoscreening
experiment by making arrays of Burkholderia antigens and
probing them with infected and naive sera. Burkholderia is a
bacterial pathogen that attacks the human respiratory system
and causes Melioidosis. Symptoms may include pain in the
chest, bones, or joints, cough, skin infections, lung nodules,
and pneumonia.28
The main considerations driving the miniaturization and
automation of immunoassays are the high cost of reagents
such as antibodies and antigens, the high cost of qualified
labor, and the long assay times involved. In this work we
have demonstrated, based on proof-of-concept results, that by
using the described reciprocating fluidic system we were able
to perform an immunoassay with a ∼75% reduction in reagent
consumption and a ∼85% reduction in assay time.
MATERIALS AND METHODS
Design of the reciprocating flow-based immunoassay
CD
The CD-based fluidic structure shown in Fig. 1 consists
of several fluidic elements that are milled 1.3 mm deep into
the CD plastic including a loading chamber, an upper cham-
ber, a pressure chamber for storing pneumatic pressure, and
a waste chamber. The design also includes a shallow reaction
chamber that is 100 μm deep and where antibodies dissolved
in the flowing liquid bond with antigens immobilized on an
array, as well as several microchannels with depths ranging
from 350 μm to 1 mm for transferring liquid between the
named chambers. After injecting 25 μl of liquid in the load-
ing reservoir, the disk starts to rotate with a high acceleration
rate and follows the angular frequency profile presented in
Fig. 2(b). The pressure differential, Pc, induced at a high
angular speed of 7000 rpm21 drives the liquid downstream,
over the antigen array, and into the pressure chamber resulting
in compression of the air trapped in the pressure chamber.27
The high rotational acceleration rate (10 000 rpm/s) prevents
the liquid from priming the siphon valve at this point. Next,
the angular speed is gradually reduced to decrease the cen-
trifugal force and release the stored pneumatic energy. This
causes the flow to reverse direction and move towards the up-
per chamber, passing over the antigen array again. The min-
imum angular frequency at which the flow reaches the crest
of the siphon for priming the siphon depends on the proper-
ties of both the liquid and the contact angle of the polymer
surface and is established empirically. This sequence of in-
creasing and decreasing angular speed is repeated for several
cycles to increase the capture rate by transporting the antibod-
ies to the array on the surface of the reaction chamber.
To transfer the sample to the waste chamber at the
end of the incubation period, angular frequency of rotation
is decreased from 10 000 rpm/s to 480 rpm to release the
pneumatic pressure abruptly and force the liquid to reach
the crest of the siphon and prime it. The capillary valve
draws the liquid almost completely into the waste chamber
and the system is ready for introduction of the next fluid.
Figure 2(a) shows the time-lapse images of the system dur-
ing operation.
Modeling of the antigen-antibody interaction
Having adequate knowledge of the kinetics of the
antigen-antibody interaction at the solid-liquid interface is
useful for optimizing assay parameters. The binding of an
antibody to an antigen is a fast and specific bimolecular in-
teraction that in a simplified form may be described by the
following equilibrium:29
Ag + Ab k f⇔
kr
Ag : Ab, (1)
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where Ag represents antigens, Ab the antibodies, Ag : Ab
the antigen-antibody complex, and k f and kr the associa-
tion and dissociation rate constants, respectively. According
to this model, antigens immobilized on the solid phase, Ag,
sequester the antibodies, Ab, from the bulk of the fluid, that
are in the vicinity forming the complex Ab : Ag on the solid
phase. Here we consider only specific interactions between
antibodies from the bulk liquid and the solid phase-bound
antigens and neglect any non-specific interactions leading to
adsorption of the antibodies directly to the solid phase. Areas
of the solid phase not spotted with antigens were blocked with
protein array blocking buffer (Whatman, USA) to prevent as
much as possible such non-specific interactions. The interac-
tion rate is controlled by a number of parameters including
the temperature, length of the molecule, the immobilization
method, and concentration of antigens and antibodies. Het-
erogeneous antigen-antibody interactions30 involve both the
liquid and the solid phase; in a first step one must consider the
transport of antibodies in the bulk of the solution to the solid
phase and next, the formation of an antibody-antigen complex
on the solid phase. Assuming a uniform velocity and con-
centration distribution along the width of the reaction chan-
nel, simulation of the solid phase antigen-antibody interaction
with both convection and diffusion as transport mechanisms
can be simplified to a two-dimensional, time-dependent sys-
tem of equations.
In the bulk of the solution, the equation of mass transport
of antibodies is written as
∂c
∂t
+ u ∂c
∂x
= D (∇2c) , (2)
where u is the velocity component in the direction along the
flow, D is the analyte diffusivity, and ∇ is the gradient op-
erator. For the second step in the heterogeneous interaction,
assuming that the rate of change in concentration of bound
antibodies on the surface (solid phase), csur f , is only a func-
tion of the rate of antibody capture occurring on the surface,
the conservation of mass equation for the reactive surface can
be simplified to
dcsurf
dt
= RH , (3)
where RH is the rate of capture on the reactive surface and
can be presented as29
RH = k f c(cs,max − csurf ) + kr csurf . (4)
Here cs,max is the concentration of antigens spotted on
the surface. To investigate the proposed reciprocating flow-
through system, the time dependent, two-dimensional system
of equations introduced above was solved by using COMSOL
(COMSOL Inc., Burlington, CA) version 3.4 running on a
personal computer with the MS Windows XP operating sys-
tem, a 2.66 GHz processor, and 4 GB of RAM. For model-
ing purposes five identical reaction sites, 100 μm in diame-
ter were defined on the lower surface of a two-dimensional
channel with a height and length of 0.1 and 6.0 mm, respec-
tively, as shown in Fig. 3. A fully developed parabolic velocity
profile of u = 6Um
(
y
/
H
) (
1 − y/H) with no slip bound-
ary conditions and a maximum velocity of Um in the cen-
FIG. 3. (Color online) Schematic showing of the capture chamber (not to
scale). The channel height and length are H = 100 μm and L = 6 mm, re-
spectively. Five capture sites of L2 = 100 μm are located on the lower wall of
the chamber and are L3 = 800 μm apart. The first capture site is located L1
= 1mm from the channel entrance. A fully developed flow with a parabolic
profile is assumed to enter the chamber.
ter of the channel was assumed for the flow in the channel.
The initial concentration of the antibodies in the flow was as-
sumed to be c(t = 0) = Cin . It was also assumed that the in-
teraction between antibodies and antigens started at time zero,
and as such, the initial concentration of the antigen/antibody
complex was csurf (t = 0) = 0. Boundary conditions included
concentration of Cin at the channel entrance, convective flux
at the channel exit (for the open channel) and zero mass flux
on all the other boundaries except for the reaction sites with
spotted antigens. In order to study the effect of various param-
eters on the rate of antibody capture, it was expedient to cast
the governing equations, their boundaries, and initial condi-
tions in a non-dimensional form as follows:
u∗ = u
Um
, x∗ = x
H
, y∗ = y
H
, c∗ = c
Cin
, t∗ = tUm
H
,
c∗surf =
csurf
cs,max
, k∗f =
k f H
Um
Cin, k∗r =
kr H
Um
.
Conservation of mass in the bulk is then normalized as
∂c∗
∂t∗
+ u ∂u
∗
∂x∗
= 1
Pe
(
∂2c∗
∂x2
+ ∂
2c∗
∂y2
)
, (5)
where Pe is the Peclet number, a non-dimensional term de-
fined as the ratio of the mass transport by convection to the
mass transport by diffusion.31
The equation for conservation of mass on the reactive sur-
face is normalized as
dc∗s
dt∗
= R∗H =
RH H
cs,maxUm
. (6)
From Eq. (4) the rate of capture term can be expressed in
a normalized format as
RH = k∗f c∗
(
1 − c∗s
)− k∗r c∗s . (7)
Boundary and initial conditions in the normalized form
can be expressed as
u∗(y∗) = 6y∗(1 − y∗), c∗(t∗ = 0) = 1,
c∗(x∗ = 0) = 1, c∗s (t∗ = 0) = 0,
convective flux: n.(−(1/Pe)∇∗c∗(x∗ = L/H )) = n.c∗u∗,
zero flux: n.
(− (1/Pe)∇∗c∗(y∗ = ±1) + c∗(y∗ = ±1)u∗)
= 0, where there is no capture of antibodies, and inward flux:
∂c∗
/
∂t∗ = k∗f c∗(1 − c∗s ) − k∗r c∗s on capture surfaces. In order
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TABLE I. Initial and boundary conditions used in computational modeling
of the interaction channel.
Passive Flow-through Reciprocating
c(t = 0) (M) 3.6 × 10−7 3.6 × 10−7 3.6 × 10−7
Cs,max (mol/m2) Five spots of 1.0, 0.3, 0.1, 0.03, or 0.01 mg/ml
Cin (M) NA 1 × 10−9 1 × 10−9
Analyte volume (μl) 10 300 10
to simulate the solid-phase antigen-antibody complex forma-
tion the conservation of mass equation (5) is coupled with
the surface-capture-rate equations (6) and (7) through the
variable c, concentration of the antibodies in the bulk of the
solution. The software then converts the governing equations
to a set of time dependent nonlinear algebraic equations. A
non-uniform triangular mesh partitions the entire geometric
domain into small elements that are connected at nodes.
The set of equations are then solved at each node for each
dependent variable using the finite element method.
The association and dissociation rate constants for pro-
tein antibodies bonding to antigens immobilized at solid
surfaces were set to 1.2×106 1/Ms and 2.9×10−41/s,
respectively.30 Some of the other parameters used in the simu-
lation including the initial concentration of the spotted antigen
array, concentration of the solution at the inlet, volume of the
consumed sample, and the reaction time are listed in Table I.
With an assumed flow rate of 40 μl/min for both flow-through
and reciprocating hybridization yields a Reynolds number
(Re) of ∼ 0.1 that categorizes the flow as fully laminar.
Immunoassay experimental setup
The experimental setup as described previously32 in-
cluded a mechanical spin-stand assembly consisting of a
NEMA 23 servomotor (PMB21B-00114-00) and an ampli-
fier/controller (PC3406Ai-001-E), both made by Pacific Sci-
entific. MS Visual Basic 2008 was used to develop the graph-
ical user interface to control the motor. Image acquisition
was performed using a digital video recording system includ-
ing a high-speed camera (Basler A301bc, 640×480 pixels,
80 fps max, 10×zoom lens), a strobe light (PerkinElmer
MVS-4200), and a retro-reflective fiber optic sensor (Ban-
ner D10 Expert Fiber-Optic Sensor), and a personal com-
puter running Windows Vista Operating System. To capture
images, a reflective rectangular tape was placed on the edge
of the CD to actuate the fiber optic sensor. As the CD rotated,
the reflective tape passed underneath the sensor, triggering the
camera and strobe light to capture one image frame per rota-
tion. A Hewlett Packcard ScanJet 9200 scanner was employed
to digitize the images of developed arrays on the disks at the
end of each experiment.
Fabrication of the microfluidics CD
The fluidic system was designed using SolidWorks 2007
(SolidWorks Corporation, Concord, MA) and fabricated by
layered assembly of polycarbonate plastic parts and pressure
sensitive adhesives as depicted in Fig. 4. Deep features were
FIG. 4. (Color online) (a) Schematic drawing of the microfluidic CD fab-
ricated from 3 thick polycarbonate plates bonded together with 2 pressure
sensitive double-sided adhesive layers. (b) Photograph of an assembled CD
with developed IgG arrays.
machined in 1.1 mm polycarbonate sheets (McMaster-Carr,
Santa Fe Springs, CA) using a QuickCircuit 5000 CNC router
machine (T-Tech Corporation, New Morgan, PA). Microchan-
nels and the reaction chamber were patterned in a 100-μm-
thick pressure sensitive double adhesive (DFM 200 made by
FLEXcon, Spencer, MA) using a Graphtec CE-2000 vinyl
cutter (Graphtec America Inc., USA). All loading and ven-
tilation holes were drilled in a blank DVD (0.6 mm thick)
using the QuickCircuit CNC. The bottom layer consisted of
a translucent CD (1.2 mm thick) coated with 100 nm of gold
on which were cast eight 6 × 6 mm nitrocellulose membranes
(Grace Bio-Labs, Bend, OR). All the layers were then aligned
and bonded together to create a fluidic system with a diameter
of 120 mm and a total thickness of 3.5 mm.
Microarray printing
Immunoglobulin G proteins (Jackson ImmunoResearch
Laboratories, West Grove, PA) with 5 different concentra-
tions ranging from 0.1 to 0.001 mg/ml and 3 Burkholderia
antigens with concentrations ranging from 0.5 to 1.0 mg/ml,
prepared as described previously,28 were spotted onto nitro-
cellulose membranes on semi-translucent gold-coated disks
using an OmniGrid 50 array printer (Genomic Solutions,
Holliston, MA). In the case of Burkholderia, each antigen of
the same concentration was printed 3 times at different area
of the pads.
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TABLE II. Comparing different steps followed in manual and reciprocating
methods for developing IgG microarrays.
Manual Reciprocating
Blocking buffer 30 min on a rocker 1 min
Goat anti-human
IgG conjugated
with AP
60 min on a rocker Varying (2.5, 5, 7, or
20 min)
TTBS Three quick washes and
3 washes of 5 min
2.5 min
TBS Three quick washes and
3 washes of 5 min
1.5 min
NBT/BCIP
substrate
4 min 3.5 min
DI water 5 min 1.5 min
The use of human immunoglobulins to optimize assay
conditions
All reagents and buffers were aliquoted for use in both
manual and centrifugal experiments carried out side-by-side
using nitrocellulose membranes cast on CDs to minimize
experimental variations. For manual experiments membranes
were dehydrated with Protein Array Blocking Buffer for
30 min and then incubated with Alkaline Phosphatase-
conjugated goat anti-human secondary antibody diluted to
1/100 in protein blocking buffer for 1 h at room temper-
ature. After 3 washes with TTBS buffer containing Tris
(hydroxymethyl)-aminomethane (Tris), pH 7.6, containing
0.05% (vol/vol) Tween 20 and 0.5 M NaCl, the slides were
developed with 1-step Nitro-Blue Tetrazolium Chloride/
5-Bromo-4-Chloro-39-Indolyphosphate p-Toluidine Salt
(NBT/BCIP) substrate (Thermo Fisher Scientific, Walthan,
MA). Immediately after the spots were developed, the
reaction was terminated by two washes with deionized (DI)
water and the disks were dried with a brief centrifugation
at 3000 rpm. Centrifugal-based assays were performed by
sequential application of the reagents and buffers to the
microfluidic system in the same order. At each step, 25 μl
of liquid was injected into the loading chamber; the disk
was mounted onto the spin-stand and rotated at angular
speeds varying with time according to the profile presented in
Fig. 2(b). Incubation times for each step varied according to
Table II. The disks were dried by piercing the pressure cham-
bers, to allow ventilation, followed by centrifugation. Images
of the developed arrays on both disks were then digitized
using a Hewlett Packard ScanJet 9200 scanner and the spot
intensities were quantified using Perkin Elmer QuantArray
software. The results were imported into a Microsoft Excel
Spreadsheet and analyzed.
Screening assays using Burkholderia antigens
The probing procedure was performed as listed in
Table I with an additional incubation step with sera of in-
fected and naive individuals (collected in Singapore) followed
by additional washing steps with TTBS before applying sec-
ondary antibody. The sera were diluted to 1/200 in Protein Ar-
ray Blocking Buffer containing a final concentration of 30%
E. coli lysate (McLabs, San Francisco, CA) and incubated
at room temperature for 1 h on a rocking platform with fre-
quency of 0.5 Hz.
RESULTS AND DISCUSSION
Increasing the incidence of encounters in bimolecular in-
teractions is of paramount interest in microarray technology.
In small structures and flows with low Re in the range of
smaller than 1–10, molecular diffusion is considered the pri-
mary method of transportation for molecules in the bulk of
the flow to the molecules bound at the solid phase. Molecu-
lar diffusion, which is the movement of particles by Brownian
motion from more concentrated to less concentrated spaces as
described by Darcy’s law is a slow and inefficient process.30
Research studies have demonstrated that bimolecular interac-
tions in micro-domains could be increased by inducing the
flow streamlines to cross each other, a phenomenon known
as chaotic advection, and hence, promoting local mixing.33, 34
That is why we designed our fluidic system to utilize cen-
trifugal and capillary forces as well as pneumatic pressure
to promote mixing and increase the frequency of bimolecu-
lar encounters. Through a series of numerical simulations we
studied the performance of the system, and in particular, the
effectiveness of flow reciprocation upon the incidence of en-
counters between solid-phase-bound antigens and antibodies.
We used the parameters of goat anti-human IgG antibodies
dissolved in the liquid phase and human IgG proteins spot-
ted on the solid phase and the kinetics of complex forma-
tion between them to solve the set of equations introduced
in the Materials and Methods section. The simulation results
presented in Fig. 5(a) compare the rate of complex forma-
tion between antigens and antibodies for different incubation
modes: passive, single flow-through, and reciprocating flow.
These graphs demonstrate similar results for both single flow-
through and reciprocating flow regimes. Reciprocation of the
flow promotes almost the same fast rate of complex forma-
tion while it consumes only a fraction of the sample volume.
The single flow-through mode achieves equilibrium state af-
ter 7 min; while the reciprocating flow mode reaches about
93% completion. This decrease is predictable since the rate
of complex formation decreases with time as the flow recip-
rocates and the concentration of the antibodies in the bulk so-
lution decreases. In comparison, the passive diffusion mode
is much slower (about 23% completion after 7 min) due to
the small diffusivity of the antibodies in the bulk of the so-
lution. Influence of the antibody concentration on the rate of
complex formation is demonstrated in the simulation results
presented in Fig. 5(b). The figure shows the concentration of
the complex as a function of time in a flow-through mode
for three initial antibody concentrations of 7.2, 14.1, and
36.0 nM. The rate of complex formation between antigens
and antibodies reaches its equilibrium state in a longer pe-
riod of time for smaller initial antibody concentrations be-
cause they will have to travel longer distances to reach the sur-
face where antigens are spotted. One way to compensate for
the small antibody concentration and boost complex forma-
tion kinetics is to transport the antibodies in the solution faster
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FIG. 5. (Color online) Simulation results. (a) Comparing three modes of in-
cubation: Single flow through, reciprocating flow, and passive diffusion be-
tween human IgG antigens and a goat anti-human IgG antibodies. (b) Effect
of the antibody concentration on the rate of complex formation. Antigen-
antibody complex formation decreases and reaches an equilibrium state in a
longer time as the initial concentration of the analyte decreases. (c) Influence
of the flow Reynolds number on the rate of complex formation. Antigen-
antibody complex formation increases and reaches an equilibrium state ear-
lier as the flow velocity increases. This difference is more visible for antibod-
ies with smaller initial concentration.
over the capture surface by increasing the velocity of the flow.
The simulation results presented in Fig. 5(c) demonstrate this
by comparing two flow-through modes with initial antibody
FIG. 6. (Color online) Experimental results; comparing the intensities of IgG
microarrays developed using the reciprocating flow system with different in-
cubation times and intensities of IgG microarrays developed using the manual
method with incubation time of 1 h.
concentrations of 36 nM and 14 nM and the Re of 0.25 and
2.5, respectively. Both modes reach the equilibrium state in
about 8 min.
We then set out to reconcile the theoretical results
with experimental data. Our first goal was to calibrate the
reciprocating flow system to get results comparable with
conventional microarray processing methods in a shorter
period of time and with a fraction of the initial consumption
of antibodies. We pursued this by probing arrays of human
serum (IgG) spots of serially diluted concentrations with
alkaline phosphatase-conjugated goat anti-human IgG sec-
ondary antibody under varying incubation times, flow rates,
and number of washes between incubations for preventing
non-specific adsorption. Figure 6 presents the average spot
intensities of developed IgG microarrays for different incu-
bation times. Table II shows the optimal times for performing
other incubation and washing steps. A reciprocating cycle of
30 s equivalent to a Re of ∼0.25 was used for experiments
carried out under flow reciprocation. The initial antibody
concentration was kept constant at 36 nM. The curves
demonstrate that after about 5 min of incubation with flow
reciprocation, the complex formation reaches its equilibrium
state and generates the same spot intensity when compared
with the results from a 1 h incubation using the conventional
method that was performed with constant mixing on a rocker.
In order to evaluate our reciprocating flow system for
performing immunoassay using human sera, we probed mi-
croarrays of Burkholderia antigens with infected and naive
serum samples and tested the system using the calibration
data obtained from our prior experiments with human sera.
Figure 7(a) compares the normalized signal intensities of ar-
rays developed using both the manual and reciprocating flow
methods. In order to account for the background noise vary-
ing over different arrays, average intensity of the IgG con-
trol spots on each array was used to normalize the intensi-
ties of spots on the same array. Data presented under infected
and naive categories are the average of data collected over
all arrays probed with infected and naive sera, respectively.
Data presented in this figure shows higher signal intensity
for arrays developed using the manual method. However, this
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FIG. 7. (Color online) Experimental results of Burkholderia immunoassay.
(a) Comparison of normalized signal intensities of infected and naive sera us-
ing reciprocating flow and passive diffusion methods. Data were normalized
by dividing the intensity of each spot over the average intensity of positive
control IgG spots. (b) Overall ratio of the signal intensity of arrays developed
using infected sera to signal intensity of arrays developed using naive sera for
both manual and reciprocating methods.
difference is due to a higher background noise, because the
same trend is repeated in both results categorized as infected
and naive. We demonstrated this relative effect in Fig. 7(b)
where the ratio of average signal intensities of arrays probed
with infected sera over that of the arrays probed with naive
sera is plotted and compared between the manual and recip-
rocating methods. Table III shows t-test between infected and
naive sera by two methods. All three antigens, BPSL3319,
BPSS1492, and BPSL2697 show significant differences be-
tween infected and naive sera by both methods. These t-test
values demonstrate that the centrifugal method can be used
for detection of Burkholderia infection, or by using the ade-
quate binders, for any particular antibody or antigen.
TABLE III. Comparing the t-test between infected and naïve sera. All three
antigens show significant differences between infected and naïve sera in both
manual and flow-reciprocating methods.
Manual (p value) Reciprocating (p value)
BPSL3319 5.40 × 10−3 2.68 × 10−2
BPSS1492 4.10 × 10−6 2.64 × 10−7
BPSL2697 3.72 × 10−6 1.75 × 10−5
CONCLUSIONS
We have presented a novel solution for the inherent prob-
lems of microarray processing on a CD using centrifugal
microfluidics. By reciprocating flow between the center and
perimeter of a disk with relatively small usable area (1002
mm2), we were able to maximize the exposure of the anti-
gen array to the serum solution. In doing so, we employed
flow-through microfluidics and active mixing phenomena to
develop a faster and semi-automated methodology for pro-
cessing microarrays. Continuing work is aimed at the com-
plete automation of the assay within the microfluidics CD and
will be reported elsewhere.
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